The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine

The heparan sulfate mimetic PG545 has been shown to exert anti-angiogenic and anti-metastatic activity in vitro and in vivo cancer models. Although much of this activity has been attributed to inhibition of heparanase and heparan sulfate-binding growth factors, it was hypothesized that PG545 may add...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Jung, Deok-Beom, Yun, Miyong, Kim, Eun-Ok, Kim, Jaekwang, Kim, Bonglee, Jung, Ji Hoon, Wang, Enfeng, Mukhopadhyay, Debabrata, Hammond, Edward, Dredge, Keith, Shridhar, Viji, Kim, Sung-Hoon
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2014
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4467129/
https://ncbi.nlm.nih.gov/pubmed/25669977
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky